Reported relationships
Latest disclosed role at each company.
| Company | Last reported as | Report date | Published |
|---|---|---|---|
| Arteris, Inc.AIP · Entity 2399 | Director | October 05, 2026 | October 06, 2026 |
| BEST BUY CO INCBBY · Entity 3305 | Director | June 12, 2026 | June 16, 2026 |
Disclosed balances
About these balances
Latest available filing per company, not a reconstructed current portfolio. Matching sequences show the last reported balance with all source rows expandable; grouping alone does not establish account ownership. Do not add unresolved positions together. Filings may omit unchanged positions, and amendments may correct only part of an older disclosure. Jointly reported shares are not necessarily this owner's personal holdings.
Arteris, Inc.
Report date October 05, 2026 · Filed October 06, 2026
| Security / award | Ownership account | Disclosed shares / units | Disclosure context |
|---|---|---|---|
| Common StockSEC Table I · non-derivative | Direct | 107,369 |
Reported balance
After 2026-10-05 transaction · row 1
1 source rowRow 1 · 2026-10-05 · Grant · Acquired 605 · Balance 107,369 F1: Fully vested restricted stock. The restricted stock represents retainer fees that the Reporting Person elected to receive in the form of shares of common stock in lieu of cash. This grant of restricted stock was made on Oct 5, 2026, based on the average trading price of Arteris, Inc. common stock for the period from August 24, 2026 through October 5, 2026, which was $22.69. F2: The Reporting Person elected to defer the receipt of shares. |
Filing footnotes · ownership attribution and instrument terms
F1: Fully vested restricted stock. The restricted stock represents retainer fees that the Reporting Person elected to receive in the form of shares of common stock in lieu of cash. This grant of restricted stock was made on Oct 5, 2026, based on the average trading price of Arteris, Inc. common stock for the period from August 24, 2026 through October 5, 2026, which was $22.69.
F2: The Reporting Person elected to defer the receipt of shares.
BEST BUY CO INC
Report date June 12, 2026 · Filed June 16, 2026
| Security / award | Ownership account | Disclosed shares / units | Disclosure context |
|---|---|---|---|
| Common StockSEC Table I · non-derivative | Direct | 38,684 |
Reported balance
After 2026-06-12 transaction · row 1
Account or security details depend on footnotes; rows are not merged.
1 source rowRow 1 · 2026-06-12 · Grant · Acquired 2,611 · Balance 38,684 F1: Shares were acquired pursuant to a grant of restricted stock units under the Issuer's Omnibus Incentive Plan. The award vests in full one year from the grant date. F2: This number reflects a periodic acquisition of shares under a dividend reinvestment plan exempt from reporting under Section 16b-3(c). |
Filing footnotes · ownership attribution and instrument terms
F1: Shares were acquired pursuant to a grant of restricted stock units under the Issuer's Omnibus Incentive Plan. The award vests in full one year from the grant date.
F2: This number reflects a periodic acquisition of shares under a dividend reinvestment plan exempt from reporting under Section 16b-3(c).
Past disclosures · reporting ended (1)
No longer tracked through insider filings. These historical balances do not imply present ownership or a zero position.
CORELOGIC, INC.
Report date June 04, 2021 · Filed June 08, 2021
Section 16 reporting ended · disclosed 2021-06-08. Current position is not established by this disclosure.
| Security / award | Ownership account | Disclosed shares / units | Disclosure context |
|---|---|---|---|
| Common StockSEC Table I · non-derivative | Direct | 0 |
Reported balance
After 2021-06-04 transaction · row 1
1 source rowRow 1 · 2021-06-04 · Disposition to issuer · Disposed 15,216.463 · Balance 0 F1: Includes 2,008 restricted stock units of CoreLogic, Inc. ("CoreLogic") subject to time-based vesting ("RSUs"). Each RSU is settled by the delivery of the underlying shares of CoreLogic common stock. F2: On June 4, 2021, pursuant to that certain Agreement and Plan of Merger (the "Merger Agreement"), dated February 4, 2021, by and among CoreLogic, Celestial-Saturn Parent Inc., a Delaware corporation ("Parent"), and Celestial-Saturn Acquisition Sub Inc., a Delaware corporation ("Acquisition Sub"), Acquisition Sub merged with and into CoreLogic, with CoreLogic surviving as a wholly owned subsidiary of Parent (the "Merger"). Pursuant to the Merger Agreement and by virtue of the Merger, in which each issued and outstanding share of CoreLogic common stock, par value $0.00001 per share, was converted into the right to receive $80 in cash, without interest (the "Merger Consideration"), each RSU held by a non-employee director that was outstanding immediately prior to the effective time of the Merger automatically vested (if unvested) and was cancelled and converted into the right to receive an amount in cash, without interest, F3: (Continued from Footnote 2) equal to the product of (A) the total number of shares of CoreLogic common stock underlying such RSU (including any shares of CoreLogic common stock in respect of dividend equivalent units credited thereon) multiplied by (B) the Merger Consideration. |
Filing footnotes · ownership attribution and instrument terms
F1: Includes 2,008 restricted stock units of CoreLogic, Inc. ("CoreLogic") subject to time-based vesting ("RSUs"). Each RSU is settled by the delivery of the underlying shares of CoreLogic common stock.
F2: On June 4, 2021, pursuant to that certain Agreement and Plan of Merger (the "Merger Agreement"), dated February 4, 2021, by and among CoreLogic, Celestial-Saturn Parent Inc., a Delaware corporation ("Parent"), and Celestial-Saturn Acquisition Sub Inc., a Delaware corporation ("Acquisition Sub"), Acquisition Sub merged with and into CoreLogic, with CoreLogic surviving as a wholly owned subsidiary of Parent (the "Merger"). Pursuant to the Merger Agreement and by virtue of the Merger, in which each issued and outstanding share of CoreLogic common stock, par value $0.00001 per share, was converted into the right to receive $80 in cash, without interest (the "Merger Consideration"), each RSU held by a non-employee director that was outstanding immediately prior to the effective time of the Merger automatically vested (if unvested) and was cancelled and converted into the right to receive an amount in cash, without interest,
F3: (Continued from Footnote 2) equal to the product of (A) the total number of shares of CoreLogic common stock underlying such RSU (including any shares of CoreLogic common stock in respect of dividend equivalent units credited thereon) multiplied by (B) the Merger Consideration.
Transaction history
JSON APIPurchases/sales include open-market and private transactions. Plan disclosure applies to the filing; individual rows may differ. “Not disclosed” is not “unplanned.”
The cutoff filters transaction history only. Company summaries and owner relationships show the latest available disclosures. Parser corrections can improve historical records.
| Transaction date | Company | Activity / security | Shares / units | Reported price | Reported value | Details |
|---|---|---|---|---|---|---|
| October 05, 2026 Filed Oct 6, 2026 20:17 UTC | Arteris, Inc. AIP · Entity 2399 | GrantCommon Stock | 605 | $0.00 | $0.00 |
DisclosureSEC source: 0001668897-26-000004 · primarydocument.xml · nonDerivative · entry 1 Munce Claudia F. · CIK 0001668897 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 107,369 F1 · shares: Fully vested restricted stock. The restricted stock represents retainer fees that the Reporting Person elected to receive in the form of shares of common stock in lieu of cash. This grant of restricted stock was made on Oct 5, 2026, based on the average trading price of Arteris, Inc. common stock for the period from August 24, 2026 through October 5, 2026, which was $22.69. F2 · shares: The Reporting Person elected to defer the receipt of shares. Read SEC document |
| July 05, 2026 Filed Jul 7, 2026 20:22 UTC | Arteris, Inc. AIP · Entity 2399 | GrantCommon Stock | 350 | $0.00 | $0.00 |
DisclosureSEC source: 0001668897-26-000003 · primarydocument.xml · nonDerivative · entry 1 Munce Claudia F. · CIK 0001668897 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 106,764 F1 · shares: Fully vested restricted stock. The restricted stock represents retainer fees that the Reporting Person elected to receive in the form of shares of common stock in lieu of cash. This grant of restricted stock was made on July 5, 2026, based on the average trading price of Arteris, Inc. common stock for the period from May 20, 2026 through July 2, 2026, which was $39.28. F2 · shares: The Reporting Person elected to defer the receipt of shares. Read SEC document |
| June 12, 2026 Filed Jun 16, 2026 20:44 UTC | BEST BUY CO INC BBY · Entity 3305 | GrantCommon Stock | 2,611 | $0.00 | $0.00 |
DisclosureSEC source: 0001225208-26-006081 · doc4.xml · nonDerivative · entry 1 Munce Claudia F. · CIK 0001668897 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 38,684 F1 · shares: Shares were acquired pursuant to a grant of restricted stock units under the Issuer's Omnibus Incentive Plan. The award vests in full one year from the grant date. F2 · balance_after: This number reflects a periodic acquisition of shares under a dividend reinvestment plan exempt from reporting under Section 16b-3(c). Read SEC document |
| June 02, 2026 Filed Jun 4, 2026 22:59 UTC | Arteris, Inc. AIP · Entity 2399 | GrantCommon Stock | 4,703 | $0.00 | $0.00 |
DisclosureSEC source: 0001668897-26-000002 · primarydocument.xml · nonDerivative · entry 1 Munce Claudia F. · CIK 0001668897 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 106,414 F1 · shares: Includes 4,703 restricted stock units ("RSUs"), each of which represents a contingent right to receive one share of the Issuer's common stock. The RSUs will vest in full on the earlier of (i) the first anniversary of the grant date and (ii) immediately before the annual meeting of the Issuer's stockholders following the grant date, subject to the reporting person continuing to provide services to Issuer's Board through such vesting date. The RSUs have no expiration date. This grant of restricted stock was made on June 2, 2026, based on the average trading price of Arteris, Inc. common stock for the period from April 21, 2026 through June 2, 2026, which was $31.89. F2 · shares: The Reporting Person elected to defer the receipt of shares. Read SEC document |
| April 05, 2026 Filed Apr 7, 2026 20:27 UTC | Arteris, Inc. AIP · Entity 2399 | GrantCommon Stock | 860 | $0.00 | $0.00 |
DisclosureSEC source: 0001668897-26-000001 · primarydocument.xml · nonDerivative · entry 1 Munce Claudia F. · CIK 0001668897 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 101,711 F1 · shares: Fully vested restricted stock. The restricted stock represents retainer fees that the Reporting Person elected to receive in the form of shares of common stock in lieu of cash. This grant of restricted stock was made on April 5, 2026, based on the average trading price of Arteris, Inc. common stock for the period from February 20, 2026 through April 2, 2026, which was $15.98. F2 · shares: The Reporting Person elected to defer the receipt of shares. Read SEC document |
| June 13, 2025 Filed Jun 17, 2025 20:42 UTC | BEST BUY CO INC BBY · Entity 3305 | GrantCommon Stock | 2,946 | $0.00 | $0.00 |
DisclosureSEC source: 0001225208-25-006026 · doc4.xml · nonDerivative · entry 1 Munce Claudia F. · CIK 0001668897 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 34,761 F1 · shares: Shares were acquired pursuant to a grant of restricted stock units under the Issuer's Omnibus Incentive Plan. The award vests in full one year from the grant date. F2 · balance_after: This number reflects a periodic acquisition of shares under a dividend reinvestment plan exempt from reporting under Section 16b-3(c). Read SEC document |
| June 03, 2025 Filed Jun 5, 2025 22:18 UTC | Arteris, Inc. AIP · Entity 2399 | GrantCommon Stock | 20,839 | $0.00 | $0.00 |
DisclosureSEC source: 0001562180-25-004520 · primarydocument.xml · nonDerivative · entry 1 Munce Claudia F. · CIK 0001668897 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 100,851 F1 · shares: Includes 20,839 restricted stock units ("RSUs"), each of which represents a contingent right to receive one share of the Issuer's common stock. The RSUs will vest in full on the earlier of (i) the first anniversary of the grant date and (ii) immediately before the annual meeting of the Issuer's stockholders following the grant date, subject to the reporting person continuing to provide services to Issuer's Board through such vesting date. The RSUs have no expiration date. Read SEC document |
| June 12, 2024 Filed Jun 14, 2024 20:33 UTC | BEST BUY CO INC BBY · Entity 3305 | GrantCommon Stock | 2,258 | $0.00 | $0.00 |
DisclosureSEC source: 0001225208-24-006851 · doc4.xml · nonDerivative · entry 1 Munce Claudia F. · CIK 0001668897 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 30,860 F1 · shares: Shares were acquired pursuant to a grant of restricted stock units under the Issuer's Omnibus Incentive Plan. The award vests in full one year from the grant date. F2 · balance_after: This number reflects a periodic acquisition of shares under a dividend reinvestment plan exempt from reporting under Section 16b-3(c). Read SEC document |
| June 04, 2024 Filed Jun 6, 2024 21:43 UTC | Arteris, Inc. AIP · Entity 2399 | GrantCommon Stock | 19,287 | $0.00 | $0.00 |
DisclosureSEC source: 0001562180-24-004764 · primarydocument.xml · nonDerivative · entry 1 Munce Claudia F. · CIK 0001668897 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 80,012 F1 · shares: Includes 19,287 restricted stock units ("RSUs"), each of which represents a contingent right to receive one share of the Issuer's common stock. The RSUs will vest in full on the earlier of (i) the first anniversary of the grant date and (ii) immediately before the Annual Meeting following the grant date, subject to the reporting person continuing to provide services to Issuer's Board through such vesting date. The RSUs have no expiration date. F2 · balance_after: Includes 26,725 restricted stock units. Read SEC document |
| January 05, 2024 Filed Jan 8, 2024 21:07 UTC | Arteris, Inc. AIP · Entity 2399 | GrantCommon Stock | 2,443 | $0.00 | $0.00 |
DisclosureSEC source: 0001562180-24-000332 · primarydocument.xml · nonDerivative · entry 1 Munce Claudia F. · CIK 0001668897 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 60,725 F1 · shares: Fully vested restricted stock. The restricted stock represents retainer fees that the Reporting Person elected to receive in the form of shares of common stock in lieu of cash. F2 · balance_after: Includes 43,903 restricted stock units. Read SEC document |
| October 05, 2023 Filed Oct 6, 2023 20:17 UTC | Arteris, Inc. AIP · Entity 2399 | GrantCommon Stock | 2,086 | $0.00 | $0.00 |
DisclosureSEC source: 0001562180-23-007235 · primarydocument.xml · nonDerivative · entry 1 Munce Claudia F. · CIK 0001668897 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 58,282 F1 · shares: Fully vested restricted stock. The restricted stock represents retainer fees that the Reporting Person elected to receive in the form of shares of common stock in lieu of cash. F2 · balance_after: Includes 43,903 restricted stock units. Read SEC document |
| July 05, 2023 Filed Jul 6, 2023 20:24 UTC | Arteris, Inc. AIP · Entity 2399 | GrantCommon Stock | 2,016 | $0.00 | $0.00 |
DisclosureSEC source: 0001562180-23-005775 · primarydocument.xml · nonDerivative · entry 1 Munce Claudia F. · CIK 0001668897 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 56,196 F1 · shares: Fully vested restricted stock. The restricted stock represents retainer fees that the Reporting Person elected to receive in the form of shares of common stock in lieu of cash. Read SEC document |
| June 14, 2023 Filed Jun 16, 2023 20:33 UTC | BEST BUY CO INC BBY · Entity 3305 | GrantCommon Stock | 2,545 | $0.00 | $0.00 |
DisclosureSEC source: 0001225208-23-006908 · doc4.xml · nonDerivative · entry 1 Munce Claudia F. · CIK 0001668897 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 27,811 F1 · shares: Shares were acquired pursuant to a grant of restricted stock units under the Issuer's Omnibus Incentive Plan. The award vests in full one year from the grant date. F2 · balance_after: This number reflects a periodic acquisition of shares under a dividend reinvestment plan exempt from reporting under Section 16b-3(c). Read SEC document |
| June 06, 2023 Filed Jun 8, 2023 21:07 UTC | Arteris, Inc. AIP · Entity 2399 | GrantCommon Stock | 29,027 | $0.00 | $0.00 |
DisclosureSEC source: 0001562180-23-004988 · primarydocument.xml · nonDerivative · entry 1 Munce Claudia F. · CIK 0001668897 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 54,180 F1 · shares: Includes 29,027 restricted stock units ("RSUs"), each of which represents a contingent right to receive one share of the Issuer's common stock. The RSUs will vest in full on the earlier of (i) the first anniversary of the grant date and (ii) immediately before the Annual Meeting following the grant date, subject to the reporting person continuing to provide services to Issuer's Board through such vesting date. The RSUs have no expiration date. Read SEC document |
| April 05, 2023 Filed Apr 7, 2023 18:56 UTC | Arteris, Inc. AIP · Entity 2399 | GrantCommon Stock | 2,839 | $0.00 | $0.00 |
DisclosureSEC source: 0001562180-23-003493 · primarydocument.xml · nonDerivative · entry 1 Munce Claudia F. · CIK 0001668897 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 25,153 F1 · shares: Fully vested restricted stock. The restricted stock represents retainer fees that the Reporting Person elected to receive in the form of shares of common stock in lieu of cash. Read SEC document |
| June 09, 2022 Filed Jun 10, 2022 20:23 UTC | BEST BUY CO INC BBY · Entity 3305 | GrantCommon Stock | 2,603 | $0.00 | $0.00 |
DisclosureSEC source: 0001225208-22-007943 · doc4.xml · nonDerivative · entry 1 Munce Claudia F. · CIK 0001668897 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 24,581 F1 · shares: Shares were acquired pursuant to a grant of restricted stock units under the Issuer's Omnibus Incentive Plan. The award vests in full one year from the grant date. F2 · balance_after: This number reflects a periodic acquisition of shares under a dividend reinvestment plan exempt from reporting under Section 16b-3(c). Read SEC document |
| May 02, 2022 Filed May 5, 2022 01:32 UTC | Arteris, Inc. AIP · Entity 2399 | GrantCommon Stock | 22,314 | $0.00 | $0.00 |
DisclosureSEC source: 0001567619-22-009545 · form4.xml · nonDerivative · entry 1 Munce Claudia F. · CIK 0001668897 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 22,314 F1 · shares: Includes 22,314 restricted stock units ("RSUs"), each of which represents a contingent right to receive one share of the Issuer's common stock. The RSUs will vest in 36 equal monthly installments from June 2, 2022. The RSUs have no expiration date. Read SEC document |
| May 02, 2022 Filed Nov 23, 2022 21:12 UTC Amendment | Arteris, Inc. AIP · Entity 2399 | GrantCommon Stock | 22,314 | $0.00 | $0.00 |
DisclosureSEC source: 0001567619-22-020843 · doc1.xml · nonDerivative · entry 1 Munce Claudia F. · CIK 0001668897 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 22,314 F1 · shares: The original form 4 inadvertently included the incorrect vesting schedule for the restricted stock units ("RSUs"). This amendment is being filed to correctly report the vesting schedule. Reflects 22,314 RSUs, each of which represents a contingent right to receive one share of the Issuer's common stock. The RSUs will vest in 3 equal annual installments starting on 5/1/2023 . The RSUs have no expiration date. F2 · balance_after: Includes 22,314 RSUs. Read SEC document |
| June 16, 2021 Filed Jun 17, 2021 20:43 UTC | BEST BUY CO INC BBY · Entity 3305 | GrantCommon Stock | 1,775 | $0.00 | $0.00 |
DisclosureSEC source: 0001225208-21-009518 · doc4.xml · nonDerivative · entry 1 Munce Claudia F. · CIK 0001668897 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 21,677 F1 · shares: Shares were acquired pursuant to a grant of restricted stock units under the Issuer's Omnibus Incentive Plan. The award vests in full one year from the grant date. F2 · balance_after: This number reflects a periodic acquisition of shares under a dividend reinvestment plan exempt from reporting under Section 16b-3(c). Read SEC document |
| June 04, 2021 Filed Jun 8, 2021 19:36 UTC | CORELOGIC, INC. CLGX · Entity 138562 | Disposition to issuerCommon Stock | 15,216.463 | $80.00 | $1,217,317.04 |
DisclosureSEC source: 0000899243-21-022642 · doc4.xml · nonDerivative · entry 1 Munce Claudia F. · CIK 0001668897 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 0 F1 · shares: Includes 2,008 restricted stock units of CoreLogic, Inc. ("CoreLogic") subject to time-based vesting ("RSUs"). Each RSU is settled by the delivery of the underlying shares of CoreLogic common stock. F2 · price: On June 4, 2021, pursuant to that certain Agreement and Plan of Merger (the "Merger Agreement"), dated February 4, 2021, by and among CoreLogic, Celestial-Saturn Parent Inc., a Delaware corporation ("Parent"), and Celestial-Saturn Acquisition Sub Inc., a Delaware corporation ("Acquisition Sub"), Acquisition Sub merged with and into CoreLogic, with CoreLogic surviving as a wholly owned subsidiary of Parent (the "Merger"). Pursuant to the Merger Agreement and by virtue of the Merger, in which each issued and outstanding share of CoreLogic common stock, par value $0.00001 per share, was converted into the right to receive $80 in cash, without interest (the "Merger Consideration"), each RSU held by a non-employee director that was outstanding immediately prior to the effective time of the Merger automatically vested (if unvested) and was cancelled and converted into the right to receive an amount in cash, without interest, F3 · price: (Continued from Footnote 2) equal to the product of (A) the total number of shares of CoreLogic common stock underlying such RSU (including any shares of CoreLogic common stock in respect of dividend equivalent units credited thereon) multiplied by (B) the Merger Consideration. Read SEC document |
| April 28, 2021 Filed Apr 30, 2021 17:20 UTC | CORELOGIC, INC. CLGX · Entity 138562 | GrantCommon Stock | 2,008 | $0.00 | $0.00 |
DisclosureSEC source: 0001127602-21-014805 · form4.xml · nonDerivative · entry 1 Munce Claudia F. · CIK 0001668897 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 15,216.463 F1 · shares: Represents a grant of Restricted Stock Units awarded on April 28, 2021 and scheduled to vest on the first anniversary of the grant date. Read SEC document |
| March 15, 2021 Filed Mar 17, 2021 18:55 UTC | CORELOGIC, INC. CLGX · Entity 138562 | GrantCommon Stock | 34.235 | $0.00 | $0.00 |
DisclosureSEC source: 0001127602-21-011201 · form4.xml · nonDerivative · entry 1 Munce Claudia F. · CIK 0001668897 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 13,208.463 F1 · shares: Represents dividend equivalent rights accrued on previously awarded restricted stock units which vest proportionately with the units to which they relate. Read SEC document |
| December 15, 2020 Filed Dec 17, 2020 18:28 UTC | CORELOGIC, INC. CLGX · Entity 138562 | GrantCommon Stock | 34.321 | $0.00 | $0.00 |
DisclosureSEC source: 0001127602-20-031858 · form4.xml · nonDerivative · entry 1 Munce Claudia F. · CIK 0001668897 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 13,174.228 F1 · shares: Represents dividend equivalent rights accrued on previously awarded restricted stock units which vest proportionately with the units to which they relate. Read SEC document |
| September 15, 2020 Filed Sep 17, 2020 18:23 UTC | CORELOGIC, INC. CLGX · Entity 138562 | GrantCommon Stock | 39.819 | $0.00 | $0.00 |
DisclosureSEC source: 0001127602-20-025344 · form4.xml · nonDerivative · entry 1 Munce Claudia F. · CIK 0001668897 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 13,139.907 F1 · shares: Represents dividend equivalent rights accrued on previously awarded restricted stock units which vest proportionately with the units to which they relate. Read SEC document |
| June 15, 2020 Filed Jun 17, 2020 19:50 UTC | CORELOGIC, INC. CLGX · Entity 138562 | GrantCommon Stock | 37 | $47.57 | $1,760.09 |
DisclosureSEC source: 0001127602-20-019988 · form4.xml · nonDerivative · entry 1 Munce Claudia F. · CIK 0001668897 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 13,100 F1 · shares: Represents dividend equivalent rights accrued on previously awarded restricted stock units which vest proportionately with the units to which they relate. Read SEC document |
| June 11, 2020 Filed Jun 12, 2020 21:13 UTC | BEST BUY CO INC BBY · Entity 3305 | GrantCommon Stock | 2,525 | $0.00 | $0.00 |
DisclosureSEC source: 0001225208-20-008946 · doc4.xml · nonDerivative · entry 1 Munce Claudia F. · CIK 0001668897 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 19,706 F1 · shares: Shares that were acquired pursuant to a grant of restricted stock units under the Issuer's Omnibus Incentive Plan. The award vests in full one year from the grant date. F2 · balance_after: This number reflects a periodic acquisition of shares under a dividend reinvestment plan exempt from reporting under Section 16b-3(c). Read SEC document |
| April 28, 2020 Filed Apr 30, 2020 14:36 UTC | CORELOGIC, INC. CLGX · Entity 138562 | GrantCommon Stock | 4,160 | $0.00 | $0.00 |
DisclosureSEC source: 0001127602-20-014750 · form4.xml · nonDerivative · entry 1 Munce Claudia F. · CIK 0001668897 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 13,063.088 F1 · shares: Represents a grant of Restricted Stock Units awarded on April 28, 2020 and scheduled to vest on the first anniversary of the grant date. Read SEC document |
| January 24, 2020 Filed Jan 28, 2020 21:28 UTC | CORELOGIC, INC. CLGX · Entity 138562 | GrantCommon Stock | 19.088 | $0.00 | $0.00 |
DisclosureSEC source: 0001127602-20-002583 · form4.xml · nonDerivative · entry 1 Munce Claudia F. · CIK 0001668897 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 8,903.088 F1 · shares: Represents dividend equivalent rights accrued on previously awarded restricted stock units which vest proportionately with the units to which they relate. Read SEC document |
| June 11, 2019 Filed Jun 13, 2019 20:48 UTC | BEST BUY CO INC BBY · Entity 3305 | GrantCommon Stock | 2,977 | $0.00 | $0.00 |
DisclosureSEC source: 0001225208-19-009216 · doc4.xml · nonDerivative · entry 1 Munce Claudia F. · CIK 0001668897 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 17,013 F1 · shares: Shares that were acquired pursuant to a grant of restricted stock units under the Issuer's Omnibus Incentive Plan. The award vests in full one year from the grant date. F2 · balance_after: This number reflects a periodic acquisition of shares under a dividend reinvestment plan exempt from reporting under Section 16b-3(c). Read SEC document |
| April 30, 2019 Filed May 2, 2019 19:32 UTC | CORELOGIC, INC. CLGX · Entity 138562 | GrantCommon Stock | 3,939 | $0.00 | $0.00 |
DisclosureSEC source: 0001127602-19-017132 · form4.xml · nonDerivative · entry 1 Munce Claudia F. · CIK 0001668897 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 8,884 F1 · shares: Represents a grant of Restricted Stock Units awarded on April 30, 2019 and scheduled to vest on the first anniversary of the grant date. Read SEC document |
| June 11, 2018 Filed Jun 13, 2018 20:35 UTC | BEST BUY CO INC BBY · Entity 3305 | GrantCommon Stock | 2,649 | $0.00 | $0.00 |
DisclosureSEC source: 0001225208-18-010624 · doc4.xml · nonDerivative · entry 1 Munce Claudia F. · CIK 0001668897 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 13,960 F1 · shares: Shares were acquired pursuant to a grant of restricted stock units under the Issuer's Omnibus Incentive Plan. The award vests in full one year from the grant date. Read SEC document |
| May 01, 2018 Filed May 3, 2018 16:46 UTC | CORELOGIC, INC. CLGX · Entity 138562 | GrantCommon Stock | 3,190 | $50.15 | $159,978.50 |
DisclosureSEC source: 0000036047-18-000069 · wf-form4_152538035696242.xml · nonDerivative · entry 1 Munce Claudia F. · CIK 0001668897 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 4,945 F1 · shares: Represents a grant of restricted stock units awarded on May 1, 2018 and scheduled to vest on the first anniversary of the grant date. Read SEC document |
| November 10, 2017 Filed Nov 14, 2017 20:35 UTC | CORELOGIC, INC. CLGX · Entity 138562 | GrantCommon Stock | 1,755 | $0.00 | $0.00 |
DisclosureSEC source: 0000036047-17-000075 · wf-form4_151070971137021.xml · nonDerivative · entry 1 Munce Claudia F. · CIK 0001668897 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 1,755 F1 · shares: Represents a grant of restricted stock units awarded on November 10, 2017 which is scheduled to vest on May 3, 2018. Read SEC document |
| June 12, 2017 Filed Jun 13, 2017 20:17 UTC | BEST BUY CO INC BBY · Entity 3305 | GrantCommon Stock | 3,414 | $0.00 | $0.00 |
DisclosureSEC source: 0001225208-17-011240 · doc4.xml · nonDerivative · entry 1 Munce Claudia F. · CIK 0001668897 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 11,311 F1 · shares: Shares were acquired pursuant to a grant of restricted stock units under the Issuer's Omnibus Incentive Plan. The award vests in full one year from the grant date. Read SEC document |
Value uses the disclosed total when available, otherwise shares × reported transaction price. It is not an estimate of exercise cash cost or investment performance.